MiR-3606-3p inhibits systemic sclerosis through targeting TGF-β type II receptor

Systemic sclerosis (SSc) is a multisystemic fibrotic disease characterized by excessive collagen deposition and extracellular matrix synthesis. Though transforming growth factor-β (TGF-β) plays a fundamental role in the pathogenesis of SSc, the mechanism by which TGF-β signaling acts in SSc remains...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cell Cycle
Main Authors: Shi, Xiangguang, Liu, Qingmei, Li, Na, Tu, Wenzhen, Luo, Ruoyu, Mei, Xueqian, Ma, Yanyun, Xu, Weihong, Chu, Haiyan, Jiang, Shuai, Du, Zhimin, Zhao, Han, Zhao, Liang, Jin, Li, Wu, Wenyu, Wang, Jiucun
格式: Artigo
語言:Inglês
出版: Taylor & Francis 2018
主題:
Research Paper
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6224271/
https://ncbi.nlm.nih.gov/pubmed/30145936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2018.1509621
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍